$TTOO - Worried about reverse split - read this 2017 article on ARNA Shares of Arena Pharmaceuticals (NASDAQ:ARNA), a biotech company focused on the development of small-molecule drugs for the treatment of autoimmune diseases and pain, soared 27% during June, according to data from S&P Global Market Intelligence. The reason for the move higher in Arena's stock is nothing short of shocking. fool.com/investing/2017/07/...
The Surprising Catalyst That Sent Arena Pharmaceuticals, Inc. Soaring 27% in June | The Motley Foolvia: The Motley Fool